Curative Ventures V LLC

Q4 2021 13F Holdings Report, Stock Holdings

Signature - Title
Bronson Crouch - Manager of CV-Immetacyte Manager LP
Location
Dallas, TX
Holdings as of
December 31, 2021
Value $
$0
Num holdings
1
Date filed
2/14/2022, 10:29 AM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Next filing
Q1 2022 - May 13, 2022
Our algorithm has found invalid data in this filing
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Bronson Crouch Manager of CV-Immetacyte Manager LP Dallas, Texas 2/13/2022